Investment adviser · CRD 301716

ADJUVANT CAPITAL, LP

Exempt reporting adviser (ERA)

Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.

NEW YORK, NY, United States · Form ADV filed Mar 27, 2026

Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →

Private funds & service providers

2 Private funds

The count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.Venture Capital Fund · Last reported Mar 27, 2026$143MGross asset value

Form D fundraising filings

Adjuvant Global Health Technology Fund, L.P.

Fund administrator CARTA FUND SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG, LLP GEORGE TOWN, Cayman Islands
Custodian FIRST-CITIZENS BANK & TRUST COMPANY NEW YORK, New York, United States Related to adviser: No
Custodian JPMORGAN CHASE & CO NEW YORK, New York, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SRS ACQUIOM, INC. SAN FRANCISCO, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG, LLP
PCAOB 1323

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

Fund details & source
Fund ID
805-3999922832
Reported beneficial owners
24
Minimum commitment
$5M
Form D file number
021-345780

Form ADV 2075732 · Mar 27, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.Venture Capital Fund · Last reported Mar 27, 2026$26.9MGross asset value

Form D fundraising filings

Adjuvant Global Health Technology Fund DE, L.P.

Fund administrator CARTA FUND SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG, LLP GEORGE TOWN, Cayman Islands
Custodian FIRST-CITIZENS BANK & TRUST COMPANY NEW YORK, New York, United States Related to adviser: No
Custodian JPMORGAN CHASE & CO. NEW YORK, New York, United States Related to adviser: No
Custodian MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED NEW YORK, New York, United States Related to adviser: No
Custodian SRS ACQUIOM, INC. SAN FRANCISCO, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG, LLP
PCAOB 1323

FIRST-CITIZENS BANK & TRUST COMPANY
LEI L9VVX1KT5TFTKS0MLF66

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
SEC 8-7221

Fund details & source
Fund ID
805-3601716105
Reported beneficial owners
15
Minimum commitment
$5M
Form D file number
021-358359

Form ADV 2075732 · Mar 27, 2026 · Schedule D 7.B.(1)

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Services & filing details

Most recent filing: Mar 27, 2026. View historical filings

Reported services

Not reported in these imported fields

Compensation

Not reported in these imported fields

Principal office

500 5TH AVENUE, SUITE 4000
NEW YORK, NY, 10110, United States

CRD 301716

Filing source

Form ADV 2075732 · Mar 27, 2026 · Items 1 & 5

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.